-
Diagnostics World | Aqutal’s advance toward a therapy response prediction test in rheumatoid arthritis; Illimis Therapeutics plans to accelerate the development of GAIA-based Alzheimer's disease therapeutics and various immune disorders; and more.
Jul 30, 2025
-
Diagnostics World | A surge in research and development around fluorophores, various types of glowing molecules used to enhance visualization during surgical procedures, is driving excitement about their potential to improve the performance of human surgeons and “pave the way” for even better autonomous robotic surgery.
Jul 24, 2025
-
Diagnostics World | Two of the great promises of AI is that it can help fill the gap in care in underserved communities and that it will give clinicians in high-demand specialties tools to meet that demand. One panel of experts at the HIMSS AI in Healthcare Forum in Brooklyn, NY, July 11-12, described how their organizations are implementing projects in exactly those areas. The HIMSS AI in Healthcare Forum brought together IT leaders, clinicians, and administrators to discuss how AI is being implemented in healthcare systems across the country.
Jul 23, 2025
-
Diagnostics World | In a proof-of-concept study, a platform integrating nanomedicine with artificial intelligence (AI) and “actual causality” analysis succeeded in pinpointing a pair of proteins thought to play key roles in the development of metastatic prostate cancer and atherosclerosis. The technology is the basis of a biotech company launching today that will use the same approach to identify potential biomarkers and drugs for treating a wide range of catastrophic diseases, including cardiovascular and neurodegenerative diseases as well as different types of cancers.
Jul 22, 2025
-
Diagnostics World | Swiss researchers have achieved a significant breakthrough in cancer diagnostics, demonstrating that advanced multiomics testing can successfully predict the most effective treatments for melanoma patients within four weeks—a timeline fast enough for real-world clinical use.
Jul 18, 2025
-
Diagnostics World | A study has revealed that phosphorylated tau (p-tau217), a key biomarker for Alzheimer's disease diagnosis, appears at even higher levels in healthy newborns than in adults with Alzheimer's disease—a finding that could reshape how clinicians interpret this widely-used diagnostic tool.
Jul 17, 2025
-
Diagnostics World | A growing number of promising young companies are developing tests that are particularly good at picking up early cancer, initially for a single type of cancer but with the potential to eventually be extended to multiple cancer types. A handful of these startups will be spotlighted at the upcoming Next Generation Dx Summit .
Jul 10, 2025
-
Diagnostics World | Molecular testing for minimal residual disease (MRD) is increasingly being used to detect cancer recurrence, and to that end many companies are actively developing assays. The tumor-informed approach based on the genetic mutations of patients has been particularly popular and often employs cell-free DNA (cfDNA) and more specifically circulating tumor DNA (ctDNA) analysis.
Jul 9, 2025
-
Diagnostics World | Researchers at the University of Chicago have published a new approach to cancer detection offering early unprecedented accuracy in identifying both early and late-stage cancers through a simple blood plasma test. The results were published today in a Brief Communication in Nature Biotechnology
Jul 8, 2025
-
Diagnostics World | For patients who suffer negative health consequences from a delayed diagnosis, new-to-the-scene digital microfluidics (DMF) technology for multifunctional testing can literally save lives. A standout in the field is Baebies (Durham, North Carolina), which has developed a pair of such platforms cleared by the U.S. Food and Drug Administration (FDA) intended for rapid point-of-care testing to aid diagnostic testing in newborns.
Jul 3, 2025
-
Diagnostics World | For patients who suffer negative health consequences from a delayed diagnosis, new-to-the-scene digital microfluidics (DMF) technology for multifunctional testing can literally save lives. A standout in the field is Baebies (Durham, North Carolina), which has developed a pair of such platforms cleared by the U.S. Food and Drug Administration (FDA) intended for rapid point-of-care testing to aid diagnostic testing in newborns.
Jul 1, 2025
-
Diagnostics World | Galatea Bio and Fabric Genomics announced a strategic collaboration this week to enhance genetic testing by incorporating both rare pathogenic variant analysis and polygenic risk scoring (PRS) to assess genetic susceptibility to common diseases.
Jun 26, 2025
-
Diagnostics World | Elkedonia SAS plans to develop the drug-like small molecule inhibitors of Elk1, a novel intracellular target that plays a pivotal role in reward brain circuits and neuroplasticity; SpliceBio will advance the clinical development of their lead gene therapy candidate, SB-007, for Stargardt disease; and more.
Jun 25, 2025
-
Diagnostics World | Veeva and Sarah Cannon Research Institute has entered a strategic collaboration; City of Hope was awarded an up to $23.7 million contract from the Advanced Research Projects Agency for Health within the US Department of Health and Human Services; and more.
Jun 24, 2025
-
Diagnostics World | Researchers at King's College London have developed a diagnostic tool that could enable doctors to sample tissue during critical medical procedures. The nanoneedle patch technology enables physicians to extract molecular information from living tissue without causing damage or killing cells—a capability that could prove especially valuable in delicate surgical situations.
Jun 20, 2025
-
Diagnostics World | Modern jet engines can generate a terabyte or more of data per hour that gets transmitted back to the engine manufacturer to ensure aircraft safety and prevent disasters from happening. Yet the human body, arguably the most important machinery of them all, gets checked only once a year or whenever something has already gone wrong.
Jun 17, 2025
-
Diagnostics World | The International Myeloma Foundation's Black Swan Research Initiative is changing how multiple myeloma is detected, monitored, and managed. From single-cell detection technologies to population-scale screening programs, these advances are setting new standards for precision oncology diagnostics.
Jun 12, 2025
-
Diagnostics World | After the human genome was sequenced in 2003, expectations were high that it would drive direct and immediate benefits for the everyday healthcare of the general population. While genomics has fundamentally altered the clinical pathways for individuals with rare diseases and cancer, it has yet to become part of routine clinical practice.
Jun 11, 2025
-
Diagnostics World | Endometriosis occurs when tissue similar to the lining of the uterus grows outside of the uterus. The condition is painful, can impede fertility, and is difficult to diagnose. But a host of new tools seek to improve diagnostics and treatment for the condition.
Jun 10, 2025
-
Diagnostics World | PrecisionLife's new diagnostic approach is addressing a critical gap in complex chronic disease detection by targeting two genetically related conditions that share remarkable similarities. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are not just clinically similar—they're genetically connected, with researchers identifying nine genes common to both disease populations.
Jun 5, 2025